Lineage Cell Therapeutics, Inc.
HealthcareAMEX:LCTX · New York Stock Exchange American
-$0.01 today
Vol 1.00M · Avg 1.18M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+56.69%
Period High
$1.96
Period Low
$0.81
Latest
$1.27
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
RAPT Therapeutics, Inc.
RAPT
$959.26M
Omeros Corporation
NASDAQ:OMER
$632.20M
Neurogene Inc.
NASDAQ:NGNE
$459.84M
PureTech Health plc
NASDAQ:PRTC
$424.07M
Autolus Therapeutics plc
NASDAQ:AUTL
$415.18M
Ocugen, Inc.
NASDAQ:OCGN
$409.61M
Benitec Biopharma Inc.
NASDAQ:BNTC
$293.44M
Fulcrum Therapeutics, Inc.
NASDAQ:FULC
$186.68M
Galectin Therapeutics Inc.
NASDAQ:GALT
$175.84M
ADC Therapeutics S.A.
NYSE:ADCT
$133.55M
What is the latest LCTX filing?
The latest filing shown is 8-K dated Jun 12, 2026.
How many recent filings does LCTX have?
Intrinsic Alpha currently shows 20 recent filings for LCTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.